Total Funding
86
57
Total FundingVenture - Series Unknown raised
Growth Score 86 in past quarter
0 pts
Heat Score 57 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
23441
Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases.
Dennis W. Wahr: Board of Directors, President & CEOPast Role: Velocimed, Co-Founder, President and CEO- Tom Griffin: Chief Financial Officer
About the Company
Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases. Nuvaira is currently working on a novel catheter-based system that has the potential to improve lung function, exercise capacity, and quality of life for patients with chronic obstructive pulmonary disease.
It was founded in 2008
and headquartered in Minneapolis, Minnesota.

